DavidJ.EschelmanMD

Interventional Radiology • Philadelphia, PA

Professor, Radiology, Sidney Kimmel Medical College of Thomas Jefferson University; Co-Director, Division of Interventional Radiology, Thomas Jefferson University Hospital

Join to view full profile

Dr. Eschelman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Eschelman's full profile

Already have an account?

Office
111 S 11th St
Ste 3390
Philadelphia, PA 19107
Phone+1 215-955-2900

Fax+1 215-923-1562

Summary

Liver-directed treatments for metastatic uveal melanoma

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Vascular and Interventional Radiology, 1991 - 1993
Boston University Medical CenterResidency, Radiology-Diagnostic, 1987 - 1991
Boston University Medical CenterInternship, Surgery, 1986 - 1987
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1986

Certifications & Licensure

PA State Medical License 1990 - 2024
CT State Medical License 1994 - 1996
American Board of Radiology Interventional Radiology and Diagnostic Radiology

Awards, Honors, & Recognition

Outstanding Clinician Award Sidney Kimmel Medical College of Thomas Jefferson University, 2024
Top Doctor in Vascular/Interventional Radiolgy Philadelphia Magazine, 2017-2024
Top Doctor in Vascular & Interventional Radiology Castle Connolly, 2015-2024
CURE OM Vision of Hope Award Melanoma Research Foundation, 2019
Fellow (FSIR) Society of Interventional Radiology
Join now to see all

Clinical Trials

TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma Start of enrollment: 2007 Oct 01
Completed
SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver Start of enrollment: 2011 Oct 31
Active, not recruiting
Phase 2
Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma Start of enrollment: 2016 Feb 01
Completed
Phase 3

Publications & Presentations

PubMed

Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Ar...
Jonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, Junsung Choi, David J Eschelman
Annals of Surgical Oncology. 2024-11-01
3 citations
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicent...
Jonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, Junsung Choi, David J Eschelman
Annals of Surgical Oncology. 2024-08-01
ASO Visual Abstract: Efficacy and Safety of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Sing...
Jonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, Junsung Choi, David J Eschelman
Annals of Surgical Oncology. 2024-08-01

Authored Content

Inferior Vena Cava Filter Placement and Retrieval Rates Among Radiologists and NonradiologistsJanuary 2018

Press Mentions

Shift in Treatment Modalities Associated with Improved Outcomes in Uveal Melanoma Patients with LiveFebruary 3rd, 2020
New Ocular Melanoma Research Grant in Honor of David EschelmanMay 3rd, 2017